CTSOVSSCTX• 6 Months (Normalized)
CTSO vs SCTX (Cytosorbents Corporation vs Scribe Therapeutics Inc.)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
SCTX Performance $21.28
+12.18%
Scribe Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin SCTX LEADS
-12.18 pts
SCTX outperforming by 12.18 percentage points
CTSOSCTX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO SCTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | CTSO Price | CTSO Gain (%) | SCTX Price | SCTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $- | $21.28 | +12.18% | - | |
| Sep 24, 2026 | $- | $21.61 | +13.92% | - | |
| Sep 23, 2026 | $4.91 | +797.62% | $26.53 | +39.85% | +757.77% |
| Sep 22, 2026 | $- | $28.07 | +47.97% | - | |
| Sep 21, 2026 | $5.51 | +907.31% | $28.05 | +47.87% | +859.44% |
| Sep 18, 2026 | $5.75 | +951.19% | $33.00 | +73.96% | +877.23% |
| Sep 17, 2026 | $5.76 | +953.02% | $32.14 | +69.43% | +883.59% |
| Sep 16, 2026 | $5.73 | +947.53% | $29.10 | +53.40% | +894.13% |
| Sep 15, 2026 | $6.06 | +1007.86% | $31.66 | +66.90% | +940.96% |
| Sep 14, 2026 | $6.07 | +1009.69% | $29.42 | +55.09% | +954.60% |
| Sep 11, 2026 | $6.41 | +1071.85% | $29.74 | +56.77% | +1015.08% |
| Sep 10, 2026 | $6.37 | +1064.53% | $29.47 | +55.35% | +1009.18% |
| Sep 09, 2026 | $6.33 | +1057.22% | $29.41 | +55.03% | +1002.19% |
| Sep 08, 2026 | $- | $31.34 | +65.21% | - | |
| Sep 04, 2026 | $0.35 | -36.01% | $28.67 | +51.13% | -87.14% |
Page 1 of 9